News | Radiology Business | June 08, 2020

Siemens Healthineers and Geisinger Partner to Drive Digital Healthcare

Partnership will make better health easier throughout Pennsylvania and in all communities that Geisinger serves

Siemens Partnership will make better health easier throughout Pennsylvania and in all communities that Geisinger serves

Getty Images

June 8, 2020 — Siemens Healthineers and Geisinger have established a 10-year Value Partnership to advance and support elements of Geisinger’s strategic priorities related to continually improving care for their patients, communities and the region.

Geisinger is a nationally recognized regional healthcare system that provides highly effective care delivery. As a leader in transforming delivery of healthcare, Geisinger has pioneered a high-performance digital care environment. A global pioneer in medical technology, Siemens Healthineers will provide Geisinger access to its latest digital health innovations, diagnostic imaging equipment, and on-site staff to support improvements during the life of the agreement. Education and workflow resources will also be available, which will provide Geisinger staff with the ability to efficiently make decisions and continually optimize workflows.

Building on a successful history of mutual research collaboration and technology enablement, Siemens Healthineers is dedicated to this long-term alliance producing impactful benefits for the patients who trust Geisinger for their care and the community.

“By expanding our relationship with Geisinger, this becomes one of the largest Value Partnership relationships in North America and will allow us to work together to improve the patient experience for residents of Pennsylvania and the region,” said David Pacitti, President and Head of the Americas, Siemens Healthineers. “As the recognized leader in digitalizing healthcare, we are excited about this next step in our relationship to transform care delivery.”

“Making better health easier by bringing world-class care close to home is central to everything we do at Geisinger,” said Matthew Walsh, chief operating officer, Geisinger.  “This partnership will allow us to continue to equip our facilities with the most advanced diagnostic imaging technology in the market to care for our patients.”

“Healthcare is changing rapidly, even more so now. This strategic partnership between Geisinger and Siemens Healthineers strengthens our ability to identify and respond to health concerns more quickly, resulting in exceptional patient care for the communities we serve in central and northeastern Pennsylvania,” said Michael Haynes, associate vice president of operations, Geisinger Radiology.

For more information: www.siemens-healthineers.com

Related Content

Radiologists of Leuwiliang General Hospital using Lunit INSIGHT CXR and INFINITT PACS G7

Radiologists of Leuwiliang General Hospital using Lunit INSIGHT CXR and Infinitt PACS G7.

News | Coronavirus (COVID-19) | January 27, 2021
January 27, 2021 — Lunit, a South Korean medical...
The American College of Radiology (ACR) actively supports President Biden’s choice of California Attorney General Xavier Becerra as Secretary of the United States Department of Health and Human Services (HHS).

California Attorney General Xavier Becerra.

News | Radiology Business | January 25, 2021
January 25, 2021 — The American College of Radiology (ACR) actively
For years telehealth has danced at the edges of healthcare
Feature | Teleradiology | January 21, 2021 | By Jef Williams
All indications point to 2021 being the year of the return path of this boomerang event that sent us all in a differe
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
An interview with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region, on the explosion of telemedicine in the COVID-19 era

Getty Images

Feature | Radiology Business | January 20, 2021 | By Melinda Taschetta-Millane
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.